State of Wyoming’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.62K Buy
610
+521
+585% +$2.9K ﹤0.01% 1760
2025
Q4
$797 Buy
89
+20
+29% +$124 ﹤0.01% 1774
2025
Q3
$255 Sell
69
-5
-7% -$14 ﹤0.01% 1807
2025
Q2
$144 Buy
+74
New +$154 ﹤0.01% 1826
2022
Q2
Sell
-1,420
Closed -$7K 2058
2022
Q1
$7K Buy
1,420
+319
+29% +$1.79K ﹤0.01% 1640
2021
Q4
$9K Buy
1,101
+214
+24% +$1.97K ﹤0.01% 1684
2021
Q3
$9K Sell
887
-503
-36% -$4.56K 0.01% 1043
2021
Q2
$13K Buy
+1,390
New +$15.8K 0.01% 987

Other funds holding NUVB

State of Wyoming's NUVB Position: Q1 2026 in Review

State of Wyoming increased its Nuvation Bio (NUVB) stake by 585% in Q1 2026, buying an estimated $2.9K and bringing the position to 610 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

State of Wyoming first reported a position in NUVB in Q2 2021 and has held it in 8 quarters since. The position peaked at $13K in Q2 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • State of Wyoming held 610 shares of Nuvation Bio worth $2.62K as of Q1 2026.
  • State of Wyoming bought 521 Nuvation Bio shares in Q1 2026, an estimated $2.9K.
  • Nuvation Bio made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1760 holding.
  • State of Wyoming first reported a position in Nuvation Bio in Q2 2021 and has held it in 8 quarters since.
  • State of Wyoming's Nuvation Bio position peaked at $13K in Q2 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.